Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells

Topic: Chemoprevention of Cancer

A special issue of Journal of Cancer Metastasis and Treatment

ISSN 2454-2857 (Online), ISSN 2394-4722 (Print)

Submission deadline: 31 May 2022

Guest Editor(s)

  • Assoc. Prof. Ching-Shu Lai
    National Kaohsiung University of Science and Technology, Kaohsiung, Taiwan.


  • Assoc. Prof. Wei-Lun Hung
    School of Food Safety,Taipei Medical University, Taipei, Taiwan.


Special Issue Introduction

Cancer is a major health problem and a leading cause of death that involves abnormal growth of cells with the potential to invade and metastasize to other part of the body. Cancer chemoprevention is defined as the use of agents to repeal, repress or thwart the cancer growth to malignancy. Numerous natural, synthetic or biologic chemical agents are able to interfere with different steps of carcinogenesis. Many in vitro and animal studies have demonstrated that chemopreventive agents can block or reverse the promotion stage of multistage carcinogenesis or retard the progression of precancerous cell into malignant ones. Besides, numerous cell-signaling pathways associated with cell proliferation and differentiation involved in anticarcinogenic actions of these agents have been identified. Importantly, emerging data have supported that epigenetic regulation is a promising strategy in cancer chemoprevention through altering DNA methylation and histone modification, modulating miRNA expression, recovering circadian rhythm, and modifying gut microbiota.

Plant-derived phytochemicals are a dominant source of chemopreventive agents. In the body, the bioaccessibility, bioavailability and metabolism of these natural compounds may greatly affect their role in cancer prevention. Besides, the combined use of the chemopreventive agents, which possess different mechanisms in cancer prevention, may work synergistically. However, the knowledge with respect to the viewpoints above are still relatively lacking and require further research.

The aim of the present special issue is to provide the principles, overviews as well as ongoing research in this field. The current knowledge of cancer chemoprevention highlighted in this special issue may provide the useful information for those entering this field and encourage new ideas for future studies.

Submission Deadline

31 May 2022

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 31 May 2022
Contacts: Olivia Zhao, Assistant Editor,

Published Articles

© 2016-2023 OAE Publishing Inc., except certain content provided by third parties